Article
The -590 IL-4 promoter polymorphism in patients with rheumatoid arthritis.
Rheumatology international - 1 Nov 2005
Pawlik Andrzej, Wrzesniewska Joanna, Florczak Marcin, Gawronska-Szklarz Barbara, Herczynska Magdalena
Abstract excerpt
Rheumatoid arthritis (RA) is a chronic inflammatory disease in which cytokines play an important role. The aim of the present study was to evaluate the -590 IL-4 promoter polymorphism in patients with RA and its association with disease activity and severity. We enrolled 94 patients with RA diagnosed according to the criteria of the American College of Rheumatology. Polymerase chain reaction amplification was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
